Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternative Combinations of ddC and AZT in HIV
NCT00002117Phase 3Completed
- Sponsor
- Roche
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of zalcitabine in human immunodeficiency virus infection (HIV), sponsored by Roche. Status: completed.
02
Drugs
zalcitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002117.